284 related articles for article (PubMed ID: 23251702)
1. Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation.
Montenegro MF; Sáez-Ayala M; Piñero-Madrona A; Cabezas-Herrera J; Rodríguez-López JN
PLoS One; 2012; 7(12):e52231. PubMed ID: 23251702
[TBL] [Abstract][Full Text] [Related]
2. Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells.
Montenegro MF; Collado-González Mdel M; Fernández-Pérez MP; Hammouda MB; Tolordava L; Gamkrelidze M; Rodríguez-López JN
BMC Cancer; 2014 Jul; 14():539. PubMed ID: 25064027
[TBL] [Abstract][Full Text] [Related]
3. Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A.
Chang JW; Hsu HS; Ni HJ; Chuang CT; Hsiung CH; Huang TH; Wang YC
PLoS One; 2010 Sep; 5(9):e12847. PubMed ID: 20877461
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
6. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.
Berletch JB; Liu C; Love WK; Andrews LG; Katiyar SK; Tollefsbol TO
J Cell Biochem; 2008 Feb; 103(2):509-19. PubMed ID: 17570133
[TBL] [Abstract][Full Text] [Related]
8. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA
Calanca N; Paschoal AP; Munhoz ÉP; Galindo LT; Barbosa BM; Caldeira JRF; Oliveira RA; Cavalli LR; Rogatto SR; Rainho CA
Epigenetics; 2019 Aug; 14(8):741-750. PubMed ID: 31062660
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer.
Kawamoto K; Okino ST; Place RF; Urakami S; Hirata H; Kikuno N; Kawakami T; Tanaka Y; Pookot D; Chen Z; Majid S; Enokida H; Nakagawa M; Dahiya R
Clin Cancer Res; 2007 May; 13(9):2541-8. PubMed ID: 17473182
[TBL] [Abstract][Full Text] [Related]
11. Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer.
Dammann RH; Richter AM; Jiménez AP; Woods M; Küster M; Witharana C
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039788
[TBL] [Abstract][Full Text] [Related]
12. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells.
Zuo S; Chen Y; Xu L; Tang Q; Zou S
J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842
[TBL] [Abstract][Full Text] [Related]
13. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter.
Strunnikova M; Schagdarsurengin U; Kehlen A; Garbe JC; Stampfer MR; Dammann R
Mol Cell Biol; 2005 May; 25(10):3923-33. PubMed ID: 15870267
[TBL] [Abstract][Full Text] [Related]
14. Eugenol modulates genomic methylation and inactivates breast cancer-associated fibroblasts through E2F1-dependent downregulation of DNMT1/DNMT3A.
Al-Kharashi LA; Bakheet T; AlHarbi WA; Al-Moghrabi N; Aboussekhra A
Mol Carcinog; 2021 Nov; 60(11):784-795. PubMed ID: 34473867
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
16. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
Meng CF; Zhu XJ; Peng G; Dai DQ
World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
[TBL] [Abstract][Full Text] [Related]
17. High frequency of promoter hypermethylation of RASSF1A in tumorous and non-tumourous tissue of breast cancer.
Yeo W; Wong WL; Wong N; Law BK; Tse GM; Zhong S
Pathology; 2005 Apr; 37(2):125-30. PubMed ID: 16028839
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the human tumor suppressor DOK1 by E2F1.
Siouda M; Yue J; Shukla R; Guillermier S; Herceg Z; Creveaux M; Accardi R; Tommasino M; Sylla BS
Mol Cell Biol; 2012 Dec; 32(23):4877-90. PubMed ID: 23028047
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
20. Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients.
Rasti M; Tavasoli P; Monabati A; Entezam M
Iran Biomed J; 2009 Oct; 13(4):199-206. PubMed ID: 19946345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
